Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma. - Corrie, P. G.; Qian, W.; Basu, B.; Valle, J. W.; Falk, S.; lwuji, C.; Wasan, H.; Palmer, D.; Scott-Brown, M.; Wadsley, J.; Arif, S.; Bridgewater, J.; et al. (British Journal of Cancer, 2020)